Inventor · disambiguated record
Robert J. Gillies
Also filed as: GILLIES ROBERT · GILLIES ROBERT J
28 granted patents·7 pending applications·336 citations·filing 1994–2024
95Inventor score
Files withH LEE MOFFITT CANCER CT & RES23GEN HOSPITAL CORP2GILLIES ROBERT J2MORSE DAVID L2H LEE MOFFITT CANCER CENTER & RES INSTITUTE INC1
Top patents by PatentIndex Score
35 records- 0194US10339653B2Systems, methods and devices for analyzing quantitative information obtained from radiological imagesH LEE MOFFITT CANCER CT & RES·Filed 2017·Granted Jul 2, 2019·26 cites·24 claims
- 0292US9721340B2Systems, methods and devices for analyzing quantitative information obtained from radiological imagesH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Aug 1, 2017·106 cites·20 claims
- 0387US10118942B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Nov 6, 2018·4 cites·12 claims
- 0487US2025129118A1Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2024·Application pending·0 cites
- 0583US10793595B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Oct 6, 2020·2 cites·12 claims
- 0680US9940709B2Systems and methods for diagnosing tumors in a subject by performing a quantitative analysis of texture-based features of a tumor object in a radiological imageH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Apr 10, 2018·4 cites·22 claims
- 0780US6663658B1Phototherapy method for treatment of acneGEN HOSPITAL CORP·Filed 2000·Granted Dec 16, 2003·94 cites·17 claims
- 0878US12173087B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 24, 2024·0 cites·18 claims
- 0977US12508329B2Radiotherapeutic and companion imaging agents to target MC1RH LEE MOFFITT CANCER CT & RES·Filed 2022·Granted Dec 30, 2025·0 cites·19 claims
- 1076US10406248B2Molecular imaging of cancer cells in vivoMORSE DAVID L·Filed 2012·Granted Sep 10, 2019·4 cites·22 claims
- 1175US7816082B2Methods of identifying pancreatic cancer cellsUNIV ARIZONA STATE·Filed 2008·Granted Oct 19, 2010·4 cites·5 claims
- 1274US11230568B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Jan 25, 2022·0 cites·18 claims
- 1373US10373314B2Systems and methods for diagnosing tumors in a subject by performing a quantitative analysis of texture-based features of a tumor object in a radiological imageH LEE MOFFITT CANCER CT & RES·Filed 2018·Granted Aug 6, 2019·1 cites·23 claims
- 1473US9441013B2Melanocortin 1 receptor ligands and methods of useGILLIES ROBERT J·Filed 2012·Granted Sep 13, 2016·2 cites·16 claims
- 1570US11406723B2Radiotherapeutic and companion imaging agents to target MC1RH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Aug 9, 2022·0 cites·12 claims
- 1669US11458212B2Molecular imaging of cancer cells in vivoH LEE MOFFITT CANCER CT & RES·Filed 2019·Granted Oct 4, 2022·0 cites·13 claims
- 1769US10183082B2PET probes of radiofluorinated carboximidamides for IDO-targeted imagingH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Jan 22, 2019·1 cites·9 claims
- 1868US11414455B2Toll-like receptor 2 ligands and methods of making and using thereofH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted Aug 16, 2022·0 cites·10 claims
- 1966US10339648B2Quantitative predictors of tumor severityH LEE MOFFITT CANCER CT & RES·Filed 2014·Granted Jul 2, 2019·3 cites·17 claims
- 2066US2020211180A1Systems and methods for diagnosing tumors in a subject by performing a quantitative analysis of texture-based features of a tumor object in a radiological imageH LEE MOFFITT CANCER CT & RES·Filed 2019·Application pending·0 cites
- 2159US10329326B2Melanocortin 1 receptor ligands and methods of useH LEE MOFFITT CANCER CT & RES·Filed 2016·Granted Jun 25, 2019·0 cites·8 claims
- 2259US5456260AFluorescence detection of cell proliferationGEN HOSPITAL CORP·Filed 1994·Granted Oct 10, 1995·84 cites·17 claims
- 2357US10827945B2Radiologically identified tumor habitatsH LEE MOFFITT CANCER CT & RES·Filed 2015·Granted Nov 10, 2020·1 cites·14 claims
- 2455US2018126013A1Radiotherapeutic and companion imaging agents to target mc1rH LEE MOFFITT CANCER CT & RES·Filed 2016·Application pending·0 cites
- 2554US12453786B2Radiomics-based treatment decision support for lung cancerH LEE MOFFITT CANCER CT & RES·Filed 2020·Granted Oct 28, 2025·0 cites·8 claims
- 2654US11763450B1Mitigating adversarial attacks on medical imaging understanding systemsUNIV SOUTH FLORIDA·Filed 2020·Granted Sep 19, 2023·0 cites·20 claims
- 2752US9486545B2Method of screening for colon cancer using biomarkersH LEE MOFFITT CANCER CT & RES·Filed 2013·Granted Nov 8, 2016·0 cites·27 claims
- 2848US9402820B2Use of pyruvate or succinate to enhance the efficacy of a hypoxia activated prodrug for the treatment of tumorsMATSUMOTO SHINGO·Filed 2012·Granted Aug 2, 2016·0 cites·17 claims
- 2947US2006104902A1Method of preselection patients for anti-VEGF, anti-HIF-1 or anti-thioredoxin therapyPOWIS GARTH·Filed 2005·Application pending·0 cites
- 3043US2016051704A1Molecular imaging probes for lung cancer intraoperative guidanceH LEE MOFFITT CANCER CT & RES·Filed 2015·Application pending·0 cites
- 3141US2022170909A1Radiomic signature for predicting lung cancer immunotherapy responseH LEE MOFFITT CANCER CT & RES·Filed 2020·Application pending·0 cites
- 3239US11077212B2Molecular imaging of cancer cells in vivoMORSE DAVID L·Filed 2011·Granted Aug 3, 2021·0 cites·11 claims
- 3334US11207429B2Method and compositions for orally administered contrast agents for MR imagingUNIV ARIZONA·Filed 2015·Granted Dec 28, 2021·0 cites·8 claims
- 3432US10258607B2Method of increasing intratumoral pHe and reducing acid-mediated invasionGILLIES ROBERT J·Filed 2012·Granted Apr 16, 2019·0 cites·8 claims
- 3526US2019185439A1Radiofluorinated carboximidamides as ido targeting pet tracer for cancer imagingH LEE MOFFITT CANCER CENTER & RES INSTITUTE INC·Filed 2017·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →